The two best pre-earnings setups in the morning scan - the ticker, the entry price, the targets and the stop-loss - in your inbox right after the open.
Healthcare, Medical Instruments & Supplies
Next earnings date for RMD: January 28, 2027 Last price $239.38. Analyst mean target $264 from 17 analysts, consensus Buy.
January 28, 2027. That is the date the AI Market Cap scanner has for RMD, and it moves as the company confirms it.
17 analysts cover RMD is Buy, and the mean target is $264 against a last price of $239.38.
RMD is in the Healthcare sector, in the Medical Instruments & Supplies industry; its market cap is $33.7B; its trailing P/E is 21.8.
Pre-earnings entry zone, analyst PE target, 3-day and 5-day implied move, and stop loss — all unlocked with a $29/month subscription.
Unlock Full Analysis →ResMed Inc. trades on NASDAQ under the ticker RMD. The company operates in the Healthcare sector — specifically Medical Instruments & Supplies.
Current analyst consensus rating: Buy with a $264 price target based on 17 analyst opinions.
EPS (trailing): $10.98 | Market Cap: $33.7B
Healthcare Medical Instruments & Supplies
Trading stocks before earnings requires understanding three key variables: the implied move (what the options market expects), the historical beat rate for the sector, and the current momentum leading into the report.
For RMD, the next earnings report is scheduled for January 28, 2027.
The implied move is calculated using at-the-money straddles — if the straddle is priced at X%, the market is pricing in approximately a ±X% move in either direction around the earnings release.
Our pre-earnings momentum scanner scores RMD across five factors to identify high-conviction setups:
The Pro subscription shows the full target range, stop loss, and implied move for RMD and all 20+ stocks in the current earnings window.